- Home
- GLPI vs EXAS Comparison
GLPI vs EXAS Comparison
Compare GLPI & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLPI
- EXAS
- Stock Information
- Founded
- GLPI 2013
- EXAS 1995
- Country
- GLPI United States
- EXAS United States
- Employees
- GLPI N/A
- EXAS N/A
- Industry
- GLPI Real Estate Investment Trusts
- EXAS Medical Specialities
- Sector
- GLPI Real Estate
- EXAS Health Care
- Exchange
- GLPI Nasdaq
- EXAS Nasdaq
- Market Cap
- GLPI 13.1B
- EXAS 10.7B
- IPO Year
- GLPI N/A
- EXAS N/A
- Fundamental
- Price
- GLPI $48.00
- EXAS $51.91
- Analyst Decision
- GLPI Buy
- EXAS Strong Buy
- Analyst Count
- GLPI 17
- EXAS 20
- Target Price
- GLPI $53.62
- EXAS $70.26
- AVG Volume (30 Days)
- GLPI 1.4M
- EXAS 2.8M
- Earning Date
- GLPI 07-24-2025
- EXAS 07-30-2025
- Dividend Yield
- GLPI 6.36%
- EXAS N/A
- EPS Growth
- GLPI 4.14
- EXAS N/A
- EPS
- GLPI 2.83
- EXAS N/A
- Revenue
- GLPI $1,550,817,000.00
- EXAS $2,828,128,000.00
- Revenue This Year
- GLPI $5.97
- EXAS $14.58
- Revenue Next Year
- GLPI $3.08
- EXAS $12.75
- P/E Ratio
- GLPI $16.91
- EXAS N/A
- Revenue Growth
- GLPI 6.14
- EXAS 11.57
- 52 Week Low
- GLPI $44.48
- EXAS $39.97
- 52 Week High
- GLPI $52.60
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- GLPI 56.15
- EXAS 44.34
- Support Level
- GLPI $47.17
- EXAS $52.00
- Resistance Level
- GLPI $48.57
- EXAS $55.90
- Average True Range (ATR)
- GLPI 0.76
- EXAS 2.31
- MACD
- GLPI 0.12
- EXAS -0.04
- Stochastic Oscillator
- GLPI 72.79
- EXAS 24.90
About GLPI Gaming and Leisure Properties Inc.
Gaming and Leisure Properties Inc, or GLP, is a real estate investment property trust whose primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in triple-net lease arrangements. The GLPI's portfolio consisted of interests in sixty one gaming and related facilities, the real property associated with thirty four gaming and related facilities operated by PENN, the real property associated with six gaming and related facilities operated by Caesars Entertainment Corporation.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.